MORC2 and cancer: As an antigen that can be effectively targeted by a specific mAb needs to be expressed on the surface of cancer cells,21 MORC2 is not an ideal target antigen to develop antibody‐based therapeutics because it is predominantly localized in the nucleus.8, 13, 15, 16